A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

NCT02905253 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
56
Enrollment
INDUSTRY
Sponsor class

Stopped The study has been terminated due to difficulties in recruiting subjects into Part C. No safety concerns contributed to the termination of the study

Conditions

Interventions

Sponsor

Idorsia Pharmaceuticals Ltd.